Stay updated on Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial
Sign up to get notified when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.

Latest updates to the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page
- Check3 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 to reflect a new software build. No study content or data on the page is affected by this change.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedAdded the exact recruitment status phrase 'No longer looking for participants' and introduced new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). Also, the 'Intervention/Treatment' label formatting was updated and the site revision moved to v3.6.0.SummaryDifference0.5%

- Check25 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating an updated version of the page. This is a small metadata update and does not modify the study text or data.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded a new site revision tag Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a deployment update to the interface, with no changes to the study details or results displayed.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the clinical trial details.SummaryDifference0.1%

- Check74 days agoChange DetectedPage revision updated to v3.5.2, replacing v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.